{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:42:11Z","timestamp":1791297731135,"version":"4.1.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,22]],"date-time":"2023-04-22T00:00:00Z","timestamp":1682121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,22]],"date-time":"2023-04-22T00:00:00Z","timestamp":1682121600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Microbiol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Urinary tract infection (UTI) is one of the most prevalent infectious diseases with worldwide health threatening. Antimicrobial resistant strains of <jats:italic>Escherichia coli<\/jats:italic> (<jats:italic>E. coli<\/jats:italic>) are a common cause of UTI which were identified as a treatment challenge. This study aimed to assay the prevalence of common \u03b2-lactam resistance genes including <jats:italic>bla<\/jats:italic><jats:sub>TEM<\/jats:sub>, <jats:italic>bla<\/jats:italic><jats:sub>SHV<\/jats:sub>, <jats:italic>bla<\/jats:italic><jats:sub>CTX-M<\/jats:sub> and <jats:italic>bla<\/jats:italic><jats:sub>CMY<\/jats:sub> and phenotypic resistance to commonly used \u03b2-lactam and fluoroquinolone antibiotics in UTIs. These factors were evaluated in various phylogenetic groups (phylotypes) of <jats:italic>E. coli<\/jats:italic> isolates. Real-time PCR was applied to detect \u03b2-lactam resistance genes and conventional PCR was used to determine the phylotypes. Phenotypic resistance against \u03b2-lactams (ceftazidime, cefotaxime, aztreonam and ceftriaxone) and fluoroquinolones (ciprofloxacin) were identified by the disc diffusion technique. The ability of extended spectrum \u03b2-lactamases (ESBLs) production in <jats:italic>E. coli<\/jats:italic> isolates was detected using the combined disc diffusion method.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The prevalence of resistance genes were 89.6% for <jats:italic>bla<\/jats:italic><jats:sub>TEM<\/jats:sub>, 44.3% for <jats:italic>bla<\/jats:italic><jats:sub>CTX-M<\/jats:sub>, 6.6% for <jats:italic>bla<\/jats:italic><jats:sub>SHV<\/jats:sub> and 0.9% for <jats:italic>bla<\/jats:italic><jats:sub>CMY<\/jats:sub>. The two high prevalent phylotypes were B2 (29.2%) and D (17.9%) followed by E (14.1%), F (9.4%), C (6.6%) and 10.3% of isolates were unknown in phylotyping. Disc diffusion results showed high prevalence of antibiotic resistance to cefotaxime (88.6%), aztreonam (83%), ceftireaxon (77.3%), ceftazidime (76.4%) and ciprofloxacin (55.6%). Totally, 52.8% of isolates were found as phenotypical ESBL-producers.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This study\u2019s results confirmed an explosion of antibiotic resistance amongst <jats:italic>E. coli<\/jats:italic> isolates from UTI against \u03b2-lactams and fluoroquinolones. Findings explain the necessity of deep changes in quantity and quality of drug resistance diagnosis and antibiotic therapy strategies. More studies are suggested to better and confident evaluations.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12866-023-02860-7","type":"journal-article","created":{"date-parts":[[2023,4,22]],"date-time":"2023-04-22T07:02:14Z","timestamp":1682146934000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["High prevalence of \u03b2-lactam and fluoroquinolone resistance in various phylotypes of Escherichia coli isolates from urinary tract infections in Jiroft city, Iran"],"prefix":"10.1186","volume":"23","author":[{"given":"Saleh","family":"Afsharikhah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Ghanbarpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parvin","family":"Mohseni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasrin","family":"Adib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahboube","family":"Bagheri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maziar","family":"Jajarmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,22]]},"reference":[{"key":"2860_CR1","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.2147\/IDR.S299846","volume":"14","author":"AS Bazaid","year":"2021","unstructured":"Bazaid AS, Saeed A, Alrashidi A, Alrashidi A, Alshaghdali K, Hammam SA, et al. Antimicrobial surveillance for bacterial uropathogens in Ha\u2019il, Saudi Arabia: a five-year multicenter retrospective study. Infect Drug Resist. 2021;14:1455.","journal-title":"Infect Drug Resist"},{"key":"2860_CR2","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.3389\/fmicb.2017.01566","volume":"8","author":"ME Terlizzi","year":"2017","unstructured":"Terlizzi ME, Gribaudo G, Maffei ME. UroPathogenic Escherichia coli (UPEC) infections: virulence factors, bladder responses, antibiotic, and non-antibiotic antimicrobial strategies. Front Microbiol. 2017;8:1566.","journal-title":"Front Microbiol"},{"key":"2860_CR3","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.1007\/s00345-019-03071-4","volume":"38","author":"R \u00d6zt\u00fcrk","year":"2020","unstructured":"\u00d6zt\u00fcrk R, Murt A. Epidemiology of urological infections: a global burden. World J Urol. 2020;38:2669\u201379.","journal-title":"World J Urol"},{"key":"2860_CR4","doi-asserted-by":"publisher","first-page":"3945","DOI":"10.2147\/IDR.S269033","volume":"13","author":"S Larramendy","year":"2020","unstructured":"Larramendy S, Deglaire V, Dusollier P, Fournier J-P, Caillon J, Beaudeau F, et al. Risk factors of extended-spectrum beta-lactamases-producing Escherichia coli community acquired urinary tract infections: a systematic review. Infect Drug Resist. 2020;13:3945.","journal-title":"Infect Drug Resist"},{"key":"2860_CR5","doi-asserted-by":"publisher","first-page":"633","DOI":"10.5811\/westjem.2020.1.45944","volume":"21","author":"PC Chardavoyne","year":"2020","unstructured":"Chardavoyne PC, Kasmire KE. Appropriateness of antibiotic prescriptions for urinary tract infections. West J Emerg Med. 2020;21:633.","journal-title":"West J Emerg Med"},{"key":"2860_CR6","doi-asserted-by":"publisher","first-page":"3472","DOI":"10.1016\/j.jmb.2019.04.002","volume":"431","author":"CL Tooke","year":"2019","unstructured":"Tooke CL, Hinchliffe P, Bragginton EC, Colenso CK, Hirvonen VHA, Takebayashi Y, et al. \u03b2-Lactamases and \u03b2-Lactamase Inhibitors in the 21st Century. J Mol Biol. 2019;431:3472\u2013500.","journal-title":"J Mol Biol"},{"key":"2860_CR7","unstructured":"Solano-G\u00e1lvez SG, Valencia-Segrove MF, Prado MJO, Boucieguez ABL, \u00c1lvarez-Hern\u00e1ndez DA, V\u00e1zquez-L\u00f3pez R. Mechanisms of resistance to quinolones. In: Antimicrobial Resistance-A One Health Perspective. London: IntechOpen; 2020. p. 25\u201348."},{"key":"2860_CR8","doi-asserted-by":"publisher","first-page":"e00088","DOI":"10.1128\/CMR.00088-17","volume":"31","author":"SR Partridge","year":"2018","unstructured":"Partridge SR, Kwong SM, Firth N, Jensen SO. Mobile genetic elements associated with antimicrobial resistance. Clin Microbiol Rev. 2018;31:e00088-e117.","journal-title":"Clin Microbiol Rev"},{"key":"2860_CR9","doi-asserted-by":"crossref","unstructured":"Pettengill JB, Kase JA, Murray MH. The population genetics, virulence, and public health concerns of escherichia coli collected from rats within an urban environment. Front Microbiol. 2021;631761.","DOI":"10.3389\/fmicb.2021.631761"},{"key":"2860_CR10","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1111\/1758-2229.12019","volume":"5","author":"O Clermont","year":"2013","unstructured":"Clermont O, Christenson JK, Denamur E, Gordon DM. The C lermont E scherichia coli phylo-typing method revisited: improvement of specificity and detection of new phylo-groups. Environ Microbiol Rep. 2013;5:58\u201365.","journal-title":"Environ Microbiol Rep"},{"key":"2860_CR11","unstructured":"Markey B, Leonard F, Archambault M, Cullinane A, Maguire D. Clinical Veterinary Microbiology E-Book. USA: Elsevier Health Sciences; 2013. p. 239\u2013274."},{"key":"2860_CR12","unstructured":"CLSI. Performance standards for antimicrobial susceptibility testing. 28th ed. CLSI supplement M100.\nWayne, PA: Clinical and laboratory standards institute; 2018. p. 30\u201337."},{"key":"2860_CR13","first-page":"16","volume":"16","author":"M Jajarmi","year":"2021","unstructured":"Jajarmi M, AsadabadiSafat A, Sakhaee E, Ghanbarpour R. Study of the presence of blaTEM, blaSHV and blaCTX-M genes in Escherichia coli strains isolated from sheep in Kerman province. Iran Vet J. 2021;16:16\u201323.","journal-title":"Iran Vet J"},{"key":"2860_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0100956","volume":"9","author":"N Roschanski","year":"2014","unstructured":"Roschanski N, Fischer J, Guerra B, Roesler U. Development of a multiplex real-time PCR for the rapid detection of the predominant beta-lactamase genes CTX-M, SHV, TEM and CIT-type AmpCs in Enterobacteriaceae. PLoS ONE. 2014;9: e100956.","journal-title":"PLoS ONE"},{"key":"2860_CR15","unstructured":"Tacconelli, E., 2017. Global priority list of antibiotic-resistant bacteria to guide research, discovery, and development, infection control Africa network. South Africa. Retrieved from https:\/\/policycommons.net\/artifacts\/1818147\/global-priority-list-of-antibiotic-resistant-bacteria-to-guide-research-discovery-and-development\/2555608\/ on 21 Apr 2023. CID: 20.500.12592\/khnnff."},{"key":"2860_CR16","doi-asserted-by":"publisher","first-page":"2384","DOI":"10.1093\/jac\/dkaa183","volume":"75","author":"AG Stewart","year":"2020","unstructured":"Stewart AG, Harris PNA, Henderson A, Schembri MA, Paterson DL. Oral cephalosporin and \u03b2-lactamase inhibitor combinations for ESBL-producing Enterobacteriaceae urinary tract infections. J Antimicrob Chemother. 2020;75:2384\u201393.","journal-title":"J Antimicrob Chemother"},{"key":"2860_CR17","first-page":"e16217","volume":"8","author":"EH Mood","year":"2015","unstructured":"Mood EH, Meshkat Z, Izadi N, Rezaei M, Jamehdar SA, Nasab MN. Prevalence of quinolone resistance genes among extended-spectrum B-lactamase-producing Escherichia coli in Mashhad Iran. Jundishapur J Microbiol. 2015;8:e16217.","journal-title":"Jundishapur J Microbiol"},{"key":"2860_CR18","doi-asserted-by":"publisher","first-page":"100947","DOI":"10.1016\/j.nmni.2021.100947","volume":"45","author":"M Sadeghi","year":"2022","unstructured":"Sadeghi M, Ebrahim-Saraie HS, Mojtahedi A. Prevalence of ESBL and AmpC genes in E coli isolates from urinary tract infections in the north of Iran. New Microbes New Infect. 2022;45:100947.","journal-title":"New Microbes New Infect"},{"key":"2860_CR19","unstructured":"Mashaiekhi S, Kheirkhah B, Amini K. Molecular study of virulence genes SHV and TEM in antibiotic resistant Escherichia coli strains isolated from urethral specimens in city of Jiroft. Razi J Med Sci. 2018;25:75\u201382."},{"key":"2860_CR20","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.2147\/IDR.S250775","volume":"13","author":"J Sun","year":"2020","unstructured":"Sun J, Du L, Yan L, Dai W, Wang Z, Xu X. Eight-year surveillance of uropathogenic escherichia coli in Southwest China. Infect Drug Resist. 2020;13:1197.","journal-title":"Infect Drug Resist"},{"key":"2860_CR21","first-page":"565","volume":"84","author":"PC Ejikeugwu","year":"2012","unstructured":"Ejikeugwu PC, Ikegbunam NM, Ugwu CM, Iroha IR, Esimone CO. Extended-spectrum \u03b2-lactamase-producing Escherichia coli isolates from suspected community acquired urinary tract infections. Eur J Sci Res. 2012;84:565\u201371.","journal-title":"Eur J Sci Res"},{"key":"2860_CR22","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s13756-016-0117-4","volume":"5","author":"T Sonda","year":"2016","unstructured":"Sonda T, Kumburu H, van Zwetselaar M, Alifrangis M, Lund O, Kibiki G, et al. Meta-analysis of proportion estimates of Extended-Spectrum-Beta-Lactamase-producing Enterobacteriaceae in East Africa hospitals. Antimicrob Resist Infect Control. 2016;5:18.","journal-title":"Antimicrob Resist Infect Control"},{"key":"2860_CR23","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.jgar.2020.10.020","volume":"23","author":"IA Critchley","year":"2020","unstructured":"Critchley IA, Cotroneo N, Pucci MJ, Jain A, Mendes RE. Resistance among urinary tract pathogens collected in Europe during 2018. J Glob Antimicrob Resist. 2020;23:439\u201344.","journal-title":"J Glob Antimicrob Resist"},{"key":"2860_CR24","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.diagmicrobio.2016.04.022","volume":"85","author":"SH Lob","year":"2016","unstructured":"Lob SH, Nicolle LE, Hoban DJ, Kazmierczak KM, Badal RE, Sahm DF. Susceptibility patterns and ESBL rates of Escherichia coli from urinary tract infections in Canada and the United States, SMART 2010\u20132014. Diagn Microbiol Infect Dis. 2016;85:459\u201365.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2860_CR25","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.1093\/cid\/ciab560","volume":"73","author":"KS Kaye","year":"2021","unstructured":"Kaye KS, Gupta V, Mulgirigama A, Joshi AV, Scangarella-Oman NE, Yu K, et al. Antimicrobial resistance trends in urine Escherichia coli isolates from adult and adolescent females in the United States from 2011 to 2019: rising ESBL strains and impact on patient management. Clin Infect Dis. 2021;73:1992\u20139.","journal-title":"Clin Infect Dis"},{"key":"2860_CR26","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1186\/s12879-019-3838-1","volume":"19","author":"O OucharMahamat","year":"2019","unstructured":"OucharMahamat O, Lounnas M, Hide M, Dumont Y, Tidjani A, Kamougam K, et al. High prevalence and characterization of extended-spectrum \u00df-lactamase producing Enterobacteriaceae in Chadian hospitals. BMC Infect Dis. 2019;19:205.","journal-title":"BMC Infect Dis"},{"key":"2860_CR27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12879-019-4717-5","volume":"20","author":"BR Dadi","year":"2020","unstructured":"Dadi BR, Abebe T, Zhang L, Mihret A, Abebe W, Amogne W. Distribution of virulence genes and phylogenetics of uropathogenic Escherichia coli among urinary tract infection patients in Addis Ababa. Ethiopia BMC Infect Dis. 2020;20:1\u201312.","journal-title":"Ethiopia BMC Infect Dis"},{"key":"2860_CR28","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.3389\/fmicb.2015.01446","volume":"6","author":"L Cantas","year":"2016","unstructured":"Cantas L, Suer K, Guler E, Imir T. High emergence of ESBL-producing E. coli cystitis: time to get smarter in Cyprus. Front Microbiol. 2016;6:1446.","journal-title":"Front Microbiol"},{"key":"2860_CR29","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.jgar.2022.05.024","volume":"30","author":"PDVM Perera","year":"2022","unstructured":"Perera PDVM, Gamage S, De Silva HSM, Jayatilleke SK, de Silva N, Aydin A, et al. Phenotypic and genotypic distribution of ESBL, AmpC \u03b2-lactamase and carbapenemase-producing Enterobacteriaceae in community-acquired and hospital-acquired urinary tract infections in Sri Lanka. J Glob Antimicrob Resist. 2022;30:115\u201322.","journal-title":"J Glob Antimicrob Resist"},{"key":"2860_CR30","doi-asserted-by":"publisher","first-page":"488","DOI":"10.3390\/microorganisms10030488","volume":"10","author":"LP Gaviria","year":"2022","unstructured":"Gaviria LP, Montsant L, Azuaje C, Gonz\u00e1lez-D\u00edaz A, Horcajada JP, Lim\u00f3n E, et al. A descriptive analysis of urinary ESBL-producing-escherichia coli in cerdanya hospital. Microorganisms. 2022;10:488.","journal-title":"Microorganisms"},{"key":"2860_CR31","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1080\/00325481.2019.1680052","volume":"132","author":"MS Bader","year":"2020","unstructured":"Bader MS, Loeb M, Leto D, Brooks AA. Treatment of urinary tract infections in the era of antimicrobial resistance and new antimicrobial agents. Postgrad Med. 2020;132:234\u201350.","journal-title":"Postgrad Med"},{"key":"2860_CR32","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.3390\/ijms21061914","volume":"21","author":"E Palma","year":"2020","unstructured":"Palma E, Tilocca B, Roncada P. Antimicrobial resistance in veterinary medicine: An overview. Int J Mol Sci. 2020;21:1914.","journal-title":"Int J Mol Sci"},{"key":"2860_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.genrep.2019.100562","volume":"18","author":"RS Ghaderi","year":"2020","unstructured":"Ghaderi RS, Yaghoubi A, Amirfakhrian R, Hashemy SI, Ghazvini K. The prevalence of genes encoding ESBL among clinical isolates of Escherichia coli in Iran: a systematic review and meta-analysis. Gene Reports. 2020;18: 100562.","journal-title":"Gene Reports"},{"key":"2860_CR34","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1089\/mdr.2019.0396","volume":"27","author":"L Jabalameli","year":"2021","unstructured":"Jabalameli L, Beigverdi R, Ranjbar HH, Pouriran R, Jabalameli F, Emaneini M. Phenotypic and genotypic prevalence of extended-spectrum \u03b2-Lactamase-producing escherichia coli: a systematic review and meta-analysis in Iran. Microb Drug Resist. 2021;27:73\u201386.","journal-title":"Microb Drug Resist"},{"key":"2860_CR35","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.3389\/fmicb.2019.02465","volume":"10","author":"E Sepp","year":"2019","unstructured":"Sepp E, Andreson R, Balode A, Bilozor A, Brauer A, Egorova S, et al. Phenotypic and molecular epidemiology of ESBL-, AmpC-, and carbapenemase-producing Escherichia coli in Northern and Eastern Europe. Front Microbiol. 2019;10:2465.","journal-title":"Front Microbiol"},{"key":"2860_CR36","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1038\/nrurol.2015.199","volume":"12","author":"HM Zowawi","year":"2015","unstructured":"Zowawi HM, Harris PNA, Roberts MJ, Tambyah PA, Schembri MA, Pezzani MD, et al. The emerging threat of multidrug-resistant Gram-negative bacteria in urology. Nat Rev Urol. 2015;12:570\u201384.","journal-title":"Nat Rev Urol"},{"key":"2860_CR37","doi-asserted-by":"crossref","unstructured":"Mendes RE, Jones RN, Woosley LN, Cattoir V, Castanheira M. Application of next-generation sequencing for characterization of surveillance and clinical trial isolates: analysis of the distribution of \u03b2-lactamase resistance genes and lineage background in the United States. Open Forum Infect Dis. 2019;6:S69\u201378.","DOI":"10.1093\/ofid\/ofz004"},{"key":"2860_CR38","first-page":"DC07","volume":"10","author":"Y Mohammed","year":"2016","unstructured":"Mohammed Y, Gadzama GB, Zailani SB, Aboderin AO. Characterization of extended-spectrum beta-lactamase from Escherichia coli and Klebsiella species from North Eastern Nigeria. J Clin diagnostic Res JCDR. 2016;10:DC07.","journal-title":"J Clin diagnostic Res JCDR"},{"key":"2860_CR39","doi-asserted-by":"publisher","first-page":"176","DOI":"10.3390\/tropicalmed5040176","volume":"5","author":"PZ Kubone","year":"2020","unstructured":"Kubone PZ, Mlisana KP, Govinden U, Abia ALK, Essack SY. Antibiotic susceptibility and molecular characterization of uropathogenic Escherichia coli associated with community-acquired urinary tract infections in urban and rural settings in South Africa. Trop Med Infect Dis. 2020;5:176.","journal-title":"Trop Med Infect Dis"},{"key":"2860_CR40","doi-asserted-by":"publisher","first-page":"663033","DOI":"10.3389\/fmicb.2021.663033","volume":"1611","author":"P Jia","year":"2021","unstructured":"Jia P, Zhu Y, Li X, Kudinha T, Yang Y, Zhang G, et al. High prevalence of extended-spectrum beta-lactamases in Escherichia coli strains collected from strictly defined community-acquired urinary tract infections in adults in china: a multicenter prospective clinical microbiological and molecular study. Front Microbiol. 2021;1611:663033.","journal-title":"Front Microbiol"},{"key":"2860_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12941-016-0144-2","volume":"15","author":"D Oduro-Mensah","year":"2016","unstructured":"Oduro-Mensah D, Obeng-Nkrumah N, Bonney EY, Oduro-Mensah E, Twum-Danso K, Osei YD, et al. Genetic characterization of TEM-type ESBL-associated antibacterial resistance in Enterobacteriaceae in a tertiary hospital in Ghana. Ann Clin Microbiol Antimicrob. 2016;15:1\u20139.","journal-title":"Ann Clin Microbiol Antimicrob"},{"issue":"1","key":"2860_CR42","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.sjbs.2014.08.002","volume":"22","author":"S Shaikh","year":"2015","unstructured":"Shaikh S, Fatima J, Shakil S, Rizvi SMD, Kamal MA. Antibiotic resistance and extended spectrum beta-lactamases: types, epidemiology and treatment. Saudi J Biol Sci. 2015;22(1):90\u2013101.","journal-title":"Saudi J Biol Sci"},{"key":"2860_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13756-020-00840-4","volume":"9","author":"J Merida-Vieyra","year":"2020","unstructured":"Merida-Vieyra J, Colsa-Ranero D, Calder\u00f3n-Casta\u00f1eda Y, Aquino-Andrade A. Detection of CMY-type beta-lactamases in Escherichia coli isolates from paediatric patients in a tertiary care hospital in Mexico. Antimicrob Resist Infect Control. 2020;9:1\u201310.","journal-title":"Antimicrob Resist Infect Control"},{"key":"2860_CR44","doi-asserted-by":"publisher","first-page":"2512","DOI":"10.3389\/fmicb.2017.02512","volume":"8","author":"NC de Stoppe","year":"2017","unstructured":"de Stoppe NC, Silva JS, Carlos C, Sato MIZ, Saraiva AM, Ottoboni LMM, et al. Worldwide phylogenetic group patterns of Escherichia coli from commensal human and wastewater treatment plant isolates. Front Microbiol. 2017;8:2512.","journal-title":"Front Microbiol"},{"key":"2860_CR45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1008866","volume":"16","author":"M Touchon","year":"2020","unstructured":"Touchon M, Perrin A, de Sousa JAM, Vangchhia B, Burn S, O\u2019Brien CL, et al. Phylogenetic background and habitat drive the genetic diversification of Escherichia coli. Plos Genet. 2020;16: e1008866.","journal-title":"Plos Genet"},{"key":"2860_CR46","doi-asserted-by":"crossref","unstructured":"Halaji M, Fayyazi A, Rajabnia M, Zare D, Pournajaf A, Ranjbar R. Phylogenetic group distribution of uropathogenic escherichia coli and related antimicrobial resistance pattern: a meta-analysis and systematic review. Front Cell Infect Microbiol. 2022;12:790184.","DOI":"10.3389\/fcimb.2022.790184"},{"key":"2860_CR47","first-page":"341","volume":"14","author":"AS Mohsin","year":"2022","unstructured":"Mohsin AS, Alsakini AH, Ali MR. Outbreak of drug resistance Escherichia coli phylogenetic F group associated urinary tract infection. Iran J Microbiol. 2022;14:341\u201350.","journal-title":"Iran J Microbiol"}],"container-title":["BMC Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-023-02860-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12866-023-02860-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-023-02860-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,22]],"date-time":"2023-04-22T07:02:26Z","timestamp":1682146946000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmicrobiol.biomedcentral.com\/articles\/10.1186\/s12866-023-02860-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,22]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2860"],"URL":"https:\/\/doi.org\/10.1186\/s12866-023-02860-7","relation":{},"ISSN":["1471-2180"],"issn-type":[{"value":"1471-2180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,22]]},"assertion":[{"value":"22 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experimental protocols were approved by the committee for ethics in biomedical research in Veterinary Faculty of Shahid Bahonar University of Kerman, Iran. Also, all methods were carried out in accordance with relevant guidelines and regulations presented by Iran National Committee for Ethics in Biomedical Research. We obtained informed consent from the all persons for sample collection.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"114"}}